Yamamoto K - Search Results

1

Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats.

Nishio M, Sakata Y, Mano T, Ohtani T, Takeda Y, Miwa T, Hori M, Masuyama T, Kondo T, Yamamoto K. Nishio M, et al. Among authors: yamamoto k. Eur J Heart Fail. 2008 May;10(5):446-53. doi: 10.1016/j.ejheart.2008.03.002. Epub 2008 Apr 8. Eur J Heart Fail. 2008. PMID: 18400557 Free article.

2

Echo doppler assessment of left ventricular function in rats with hypertensive hypertrophy.

Ono K, Masuyama T, Yamamoto K, Doi R, Sakata Y, Nishikawa N, Mano T, Kuzuya T, Takeda H, Hori M. Ono K, et al. Among authors: yamamoto k. J Am Soc Echocardiogr. 2002 Feb;15(2):109-17. doi: 10.1067/mje.2002.115034. J Am Soc Echocardiogr. 2002. PMID: 11836485

3

New attempt of ultrasonic tissue characterization: decreased chaos in myocardial echo in patients with dilated cardiomyopathy.

Masuyama T, Yamamoto K, Nishikawa N, Sakata Y, Mano T, Hori M, Sonoyama T, Ito T, Yoshikawa Y. Masuyama T, et al. Among authors: yamamoto k. Ultrasound Med Biol. 2002 Jan;28(1):93-9. doi: 10.1016/s0301-5629(01)00496-3. Ultrasound Med Biol. 2002. PMID: 11879956

4

Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.

Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Hori M. Yamamoto K, et al. J Hypertens. 2002 Apr;20(4):753-61. doi: 10.1097/00004872-200204000-00035. J Hypertens. 2002. PMID: 11910313

5

[Economy class syndrome associated with electrocardiographic changes that required discrimination from coronary artery disease].

Furumatsu Y, Kamei J, Nakatani D, Yamaguchi O, Aoki K, Hasegawa S, Yamamoto K, Masuyama T, Hori M. Furumatsu Y, et al. Among authors: yamamoto k. Nihon Naika Gakkai Zasshi. 2002 Mar 10;91(3):1034-5. doi: 10.2169/naika.91.1034. Nihon Naika Gakkai Zasshi. 2002. PMID: 11985077 Japanese. No abstract available.

6

Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.

Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, Miwa T, Sugawara M, Yamaguchi Y, Ookawara T, Suzuki K, Hori M. Yamamoto K, et al. Cardiovasc Res. 2002 Jul;55(1):76-82. doi: 10.1016/s0008-6363(02)00341-3. Cardiovasc Res. 2002. PMID: 12062710

7

Angiotensin II type 1 and endothelin type A receptor antagonists modulate the extracellular matrix regulatory system differently in diastolic heart failure.

Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishikawa N, Miwa T, Hori M, Masuyama T. Yoshida J, et al. Among authors: yamamoto k. J Hypertens. 2003 Feb;21(2):437-44. doi: 10.1097/00004872-200302000-00037. J Hypertens. 2003. PMID: 12569276

8

Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.

Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T. Sakata Y, et al. Among authors: yamamoto k. Cardiovasc Res. 2003 Mar;57(3):757-65. doi: 10.1016/s0008-6363(02)00722-8. Cardiovasc Res. 2003. PMID: 12618237

9

Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.

Nishikawa N, Yamamoto K, Sakata Y, Mano T, Yoshida J, Miwa T, Takeda H, Hori M, Masuyama T. Nishikawa N, et al. Among authors: yamamoto k. Cardiovasc Res. 2003 Mar;57(3):766-74. doi: 10.1016/s0008-6363(02)00792-7. Cardiovasc Res. 2003. PMID: 12618238

10

[Cardiac transplantation].

Yamamoto K, Takashima S, Masuyama T. Yamamoto K, et al. Nihon Rinsho. 2003 May;61(5):845-50. Nihon Rinsho. 2003. PMID: 12755013 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,604 results

Search Page

Filters